We are monitoring the impact of COVID-19 on North America Precision Medicine Software Market Get in touch with us for detailed analysis Know More
Pulished Date July, 2021
ID: 11863
Share on
Share on

North America Precision Medicine Software Market Research Report – Segmented By Delivery Mode, Application, End User & Country (The United States, Canada and Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: July, 2021
ID: 11863
Pages: 100

North American Precision Medicine Software Market Size (2021 to 2026)

The size of the North American precision medicine software market is estimated to be growing at a significant CAGR during the forecast period.

The market has experienced significant development over the past decade. The number of companies, government, and private research institutes involved in the industry has grown steadily. The continued and tireless efforts of scientists to assess the human genome and identify genomic biomarkers have been successful. In addition, government initiatives have also played an important role in the development of the market. For example, in 2015, the U.S. government launched the Precision Medicine Initiative to create a national research cohort of more than one million Americans who donate their genetic information to help find several new ways to improve disease identification and treatment. With all of these ongoing efforts, the number of drugs approved for precision medicine increases, thus driving the precision medicine software market.

The increase in R&D activities for other diseases is expected to increase the number of drugs for cardiovascular, infectious, and neurological diseases. The number of precision medicine software is expected to have a lucrative growth rate, and the continued expansion of precision medicine software will drive industry growth.

On the other hand, the high cost and the potential threat to personal health data are factors that can hamper the expansion of the North American precision medicine software market.

Impact of COVID-19 on the North American Precision Medicine Software Market:

In the midst of the current pandemic, the precision medicine software market is advancing at breakneck speed. As a result, the healthcare industry focuses on precision medicine and genetic research to better understand the response to COVID-19, measure its impact, and uncover potential therapies. Additionally, the COVID-19 pandemic affected the regional economy and had a major impact on the functioning of general hospital care for non-COVID-19 patients across the region.

Precision medicine has seen collaborative efforts between governments, institutions, and researchers to develop effective treatments. For instance, the San Antonio partnership for precision medicine collaborated funds for projects; these projects focus on cellular interactions like proteins from the immune system and the respiratory tract, generate responses to the virus, and how researchers benefit from this data to develop therapies.

This research report on the North American precision medicine software market has been segmented and sub-segmented into the following categories:

By Delivery Mode:

  • Web & Cloud-Based
  • On-Premise

By Application:

  • Oncology
  • Pharmacogenomics
  • Rare Diseases
  • Other Applications

By End User:

  • Healthcare Providers
  • Research Centers and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

By Country:

  • The United States
  • Canada
  • Rest of North America

Geographically, improved healthcare infrastructure and massive R&D spending are expected to fuel the precision medicine software market in the United States. There have been significant advances in precision medicine for certain types of cancer treatments, such as colorectal cancer and breast cancer. According to the American Cancer Society, approximately 1.9 million new cancer cases and 606,550 cancer deaths were diagnosed in the United States. This should help in the development of precision cancer treatments. The precision medicine initiative in the United States includes continued efforts through the Department of Veterans Affairs (VA), which has enrolled more than 450,100 veterans in the Million Veteran (MVP) program, a research cohort directed by the participants to develop one of the largest databases in the world for precision medicine.

According to the United States National Clinical Trials Registry, approximately 195 registered clinical trials related to precision drugs are expected to drive market growth in the future. In addition, the Food and Drug Administration, the Office of the National Health IT Coordinator, and the Office for Civil Rights in the United States announced in 2016 that they would develop research and data capabilities, tools techniques, and policies to accelerate precision medicine software, thereby driving the overall growth of the market in the country.

Canada launched a national program to promote the clinical implementation of precision medicine software to build a national rare disease cohort. This is expected to support the growth of the market in the coming years.

KEY MARKET PLAYERS:

Companies such as SOPHiA GENETICS SA, Syapse, Inc., Foundation Medicine, Inc., 2bPrecise LLC, Fabric Genomics, Human Longevity, Inc., Translational Software, Inc., Gene42, Inc., IBM Watson Group, LifeOmic Health, LLC, Sunquest Information Systems Inc., Koninklijke Philips N.V., and Flatiron Health, Inc. are estimated to play a significant role in the North American precision medicine software market during the forecast period.

  1. Introduction                                                          
    1. Market Definition                                               
    2. Scope of the report                                            
    3. Study Assumptions
    4. Base Currency, Base Year and Forecast Periods
  2. Research Methodology
    1. Analysis Design
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Data Modelling
      4. Expert Validation
    3. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking
      1. Market share analysis
      2. Products/Service
      3. Regional Presence
    2. Mergers & Acquisition Landscape
    3. Joint Ventures & Collaborations
  6. Market Segmentation
    1. Precision Medicine Software Market, By Delivery
      1. Web & Cloud Based
      2. On-Premise
      3. Market Size Estimations & Forecasts (2021-2026)
      4. Y-o-Y Growth Rate Analysis
      5. Market Attractiveness Index
    2. Precision Medicine Software Market, By Application
      1. Oncology
      2. Pharmacogenomics
      3. Rare Diseases
      4. Other Applications
      5. Market Size Estimations & Forecasts (2021-2026)
      6. Y-o-Y Growth Rate Analysis
      7. Market Attractiveness Index
    3. Precision Medicine Software Market, By End User
      1. Healthcare Providers
      2. Research Centers and Academic Institutes
      3. Pharmaceutical and Biotechnology Companies
      4. Other End Users
      5. Market Size Estimations & Forecasts (2021-2026)
      6. Y-o-Y Growth Rate Analysis
      7. Market Attractiveness Index
  7. Geographical Landscape
    1. Precision Medicine Software Market, by Region
    2. North America - Market Analysis (2021 to 2026)
      1. By Country
        1. USA
        2. Canada
  8. Key Player Analysis
    1. SOPHiA GENETICS SA
      1. Business Description
      2. Products/Service
      3. Financials                             
      4. SWOT Analysis
      5. Recent Developments
      6. Analyst Overview
    2. Syapse, Inc.
    3. Foundation Medicine, Inc.
    4. 2bPrecise LLC
    5. Fabric Genomics
    6. Human Longevity, Inc.
    7. Translational Software, Inc.
    8. Gene42, Inc.
    9. IBM Watson Group
    10. LifeOmic Health, LLC
    11. Sunquest Information Systems Inc.
    12. Koninklijke Philips N.V.
    13. Flatiron Health, Inc.
  9. Market Outlook & Investment Opportunities
  10. Appendix                                               
    1. List of Tables
    2. List of Figures
  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of delivery mode, application and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. North America Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  2. North America Web & Cloud-Based Market, By Region, From 2021 to 2026 (USD Billion)
  3. North America On-Premise Market, By Region, From 2021 to 2026 (USD Billion)
  4. North America Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  5. North America Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  6. North America Pharmacogenomics Market, By Region, From 2021 to 2026 (USD Billion)
  7. North America Rare Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  8. North America Other Applications Market, By Region, From 2021 to 2026 (USD Billion)
  9. North America Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  10. North America Healthcare Providers Market, By Region, From 2021 to 2026 (USD Billion)
  11. North America Research Centers and Academic Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  12. North America Pharmaceutical and Biotechnology Companies Market, By Region, From 2021 to 2026 (USD Billion)
  13. North America Other End Users Market, By Region, From 2021 to 2026 (USD Billion)
  14. United States Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  15. United States Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  16. United States Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)
  17. Canada Precision Medicine Software Market, By Delivery Mode, From 2021 to 2026 (USD Billion)
  18. Canada Precision Medicine Software Market, By Application, From 2021 to 2026 (USD Billion)
  19. Canada Precision Medicine Software Market, By End User, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample